Assembly of E-cadherin–based adherens junctions (AJ) is obligatory for establishment of polarized epithelia and plays a key role in repressing the invasiveness of many carcinomas. Here we show that type Iγ phosphatidylinositol phosphate kinase (PIPKIγ) directly binds to E-cadherin and modulates E-cadherin trafficking. PIPKIγ also interacts with the μ subunits of clathrin adaptor protein (AP) complexes and acts as a signalling scaffold that links AP complexes to E-cadherin. Depletion of PIPKIγ or disruption of PIPKIγ binding to either E-cadherin or AP complexes results in defects in E-cadherin transport and blocks AJ assembly. An E-cadherin germline mutation that loses PIPKIγ binding and shows disrupted basolateral membrane targeting no longer forms AJs and leads to hereditary gastric cancers. These combined results reveal a novel mechanism where PIPKIγ serves as both a scaffold, which links E-cadherin to AP complexes and the trafficking machinery, and a regulator of trafficking events via the spatial generation of phosphatidylinositol-4,5-bisphosphate.
Skip Nav Destination
Article navigation
29 January 2007
Article|
January 29 2007
Type Iγ phosphatidylinositol phosphate kinase modulates adherens junction and E-cadherin trafficking via a direct interaction with μ1B adaptin
Kun Ling,
Kun Ling
1Program in Molecular and Cellular Pharmacology, Department of Pharmacology, University of Wisconsin Medical School, Madison, WI 53706
Search for other works by this author on:
Shawn F. Bairstow,
Shawn F. Bairstow
1Program in Molecular and Cellular Pharmacology, Department of Pharmacology, University of Wisconsin Medical School, Madison, WI 53706
Search for other works by this author on:
Chateen Carbonara,
Chateen Carbonara
1Program in Molecular and Cellular Pharmacology, Department of Pharmacology, University of Wisconsin Medical School, Madison, WI 53706
Search for other works by this author on:
Dmitry A. Turbin,
Dmitry A. Turbin
2Genetic Pathology Evaluation Centre of the Departments of Pathology, British Columbia Cancer Agency, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia V5Z 4E6, Canada
Search for other works by this author on:
David G. Huntsman,
David G. Huntsman
2Genetic Pathology Evaluation Centre of the Departments of Pathology, British Columbia Cancer Agency, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia V5Z 4E6, Canada
Search for other works by this author on:
Richard A. Anderson
Richard A. Anderson
1Program in Molecular and Cellular Pharmacology, Department of Pharmacology, University of Wisconsin Medical School, Madison, WI 53706
Search for other works by this author on:
Kun Ling
1Program in Molecular and Cellular Pharmacology, Department of Pharmacology, University of Wisconsin Medical School, Madison, WI 53706
Shawn F. Bairstow
1Program in Molecular and Cellular Pharmacology, Department of Pharmacology, University of Wisconsin Medical School, Madison, WI 53706
Chateen Carbonara
1Program in Molecular and Cellular Pharmacology, Department of Pharmacology, University of Wisconsin Medical School, Madison, WI 53706
Dmitry A. Turbin
2Genetic Pathology Evaluation Centre of the Departments of Pathology, British Columbia Cancer Agency, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia V5Z 4E6, Canada
David G. Huntsman
2Genetic Pathology Evaluation Centre of the Departments of Pathology, British Columbia Cancer Agency, Vancouver General Hospital and University of British Columbia, Vancouver, British Columbia V5Z 4E6, Canada
Richard A. Anderson
1Program in Molecular and Cellular Pharmacology, Department of Pharmacology, University of Wisconsin Medical School, Madison, WI 53706
Correspondence to Richard A. Anderson: [email protected]
Abbreviations used in this paper: AJ, adherens junction; AP, clathrin adaptor protein; ECDT, E-cadherin cytoplasmic domain; HEK, human embryonic kidney; HR, heptad repeat; PI4,5P2, phosphatidylinositol-4,5-bisphosphate; PIPKI, type I phosphatidylinositol phosphate kinase; PM, plasma membrane; TfnR, transferrin receptor.
Received:
June 06 2006
Accepted:
December 15 2006
Online ISSN: 1540-8140
Print ISSN: 0021-9525
The Rockefeller University Press
2007
J Cell Biol (2007) 176 (3): 343–353.
Article history
Received:
June 06 2006
Accepted:
December 15 2006
Connected Content
Related
Caught in the middle
Citation
Kun Ling, Shawn F. Bairstow, Chateen Carbonara, Dmitry A. Turbin, David G. Huntsman, Richard A. Anderson; Type Iγ phosphatidylinositol phosphate kinase modulates adherens junction and E-cadherin trafficking via a direct interaction with μ1B adaptin . J Cell Biol 29 January 2007; 176 (3): 343–353. doi: https://doi.org/10.1083/jcb.200606023
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
See also
Email alerts
Advertisement
Advertisement